Thomas Frodl, MD
- 3Articles
- 12.3KReads1
- 2004–2010Active
- 26Collaborators
- 58Citations2
About
Thomas Frodl, MD, has contributed to research on major depressive disorder (MDD), focusing on brain activation differences associated with antidepressants such as mirtazapine and venlafaxine. His work includes studies on predicting clinical response to serotonergic and noradrenergic antidepressants using auditory evoked potentials, as well as longitudinal analyses of hippocampal and amygdala changes in patients with MDD. Frodl's publications, spanning from 2004 to 2010, often involved collaboration with co-authors including Hans-Jürgen Möller and Arun L. W. Bokde.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
